Niewoehner D. Structure-function relationships: the pathophysiology of airflow obstruction. In Stockley R, Rennard S. Rabe K, Celli B, eds. Chronic Obstructive Pulmonary Disease. Hoboken, NJ: Blackwell, 2007: 3-19.
Fernando J Martinez, James F Donohue, Stephen I Rennard. The future of chronic obstructive pulmonary disease treatment-difficulties of and barriers to drug development. Lancet 2011; 378: 1027-37
OM, A.-S. (2011). Stem cell therapy for Alzheimer’s disease. CNS Neurological
Disorders Drug Targets, 459-85
McKhann GM, K. D. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.Alzheimer’s and Dementia , 263-269.
Aesth Plast Surg (2012). Fat Grafting Versus Adipose-Derived Stem Cell Therapy: Distinguishing Indications, Techniques, and Outcomes. 36:704–713 DOI 10.1007/s00266-011-9835-4
Burt RK, Craig RM, Milanetti F et al. Blood 2010;116:6123–32.
World J Surg (2013). Intra-arterial Allogeneic Mesenchymal Stem Cells for Critical Limb Ischemia are Safe and Efficacious: Report of a Phase I Study. 37:915–922 DOI 10.1007/s00268-012-1892-6
BioResearch Open Access. Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells Volume 4.1, 2015 DOI: 10.1089/biores.2014.0042
Clinical and experimental gastroenterology. Jan16, 2010. Stem cell therapeutics: potential in the treatment of inflammatory bowel disease. pp 1-11
Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin Exp Med (2014) 14:13–24 DOI 10.1007/s10238-012-0218-1
Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. Across Speciality Collaboration, UK (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. 10.1016/S0140-6736(20)30628-0.
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3.
Han H., Yang L., Liu R., Liu F., Wu K.L., Li J. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection [published online ahead of print, 2020 Mar 16] Clin Chem Lab Med. 2020 /j/cclm.ahead-of-print/cclm-2020-0188/cclm-2020-0188.xml.doi:10.1515/cclm-2020-0188.
Leng Z., Zhu R., Hou W., Feng Y., Yang Y., Han Q. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020;Enfermedades neuronales y terapia celular
Gentile, P., & Garcovich, S. (2019). Advances in regenerative stem cell therapy in androgenic alopecia and hair loss: Wnt pathway, Growth-Factor, and mesenchymal stem cell signaling impact analysis on cell growth and hair follicle development. Cells, 466(8), cells8050466.
J., B. J., Sanchez, T., & Sancho, G. (18d. C.). El potencial de las células madre mesenquimales para tratar el lupus. INTRAMED, 27(13), 261-265.
Alvaréz Hernandez, P., & De la Mata Llord, J. (2022). Tratamiento de la artrosis de rodilla con células mesenquimales estromales expandidas: Revisión sistemática de la literatura. Reumatologia Clinica, 18(1), 49-55. https://doi.org/10.1016/j.reuma.2020.10.007
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.